Report Overview
Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders. Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.
The global Long Acting Drug Delivery market size was estimated at USD 1536 million in 2023 and is projected to reach USD 2573.09 million by 2032, exhibiting a CAGR of 5.90% during the forecast period.
North America Long Acting Drug Delivery market size was estimated at USD 441.74 million in 2023, at a CAGR of 5.06% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Long Acting Drug Delivery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Long Acting Drug Delivery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Long Acting Drug Delivery market in any manner.
Global Long Acting Drug Delivery Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Creative Biolabs
Market Segmentation (by Type)
Device
Parenteral Injections
Market Segmentation (by Application)
Hospital
Specialty Clinics
Clinical Research Institutes
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Long Acting Drug Delivery Market
Overview of the regional outlook of the Long Acting Drug Delivery Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long Acting Drug Delivery Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Long Acting Drug Delivery, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Long Acting Drug Delivery
1.2 Key Market Segments
1.2.1 Long Acting Drug Delivery Segment by Type
1.2.2 Long Acting Drug Delivery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Long Acting Drug Delivery Market Overview
2.1 Global Market Overview
2.1.1 Global Long Acting Drug Delivery Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Long Acting Drug Delivery Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Long Acting Drug Delivery Market Competitive Landscape
3.1 Global Long Acting Drug Delivery Sales by Manufacturers (2019-2025)
3.2 Global Long Acting Drug Delivery Revenue Market Share by Manufacturers (2019-2025)
3.3 Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Long Acting Drug Delivery Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Long Acting Drug Delivery Sales Sites, Area Served, Product Type
3.6 Long Acting Drug Delivery Market Competitive Situation and Trends
3.6.1 Long Acting Drug Delivery Market Concentration Rate
3.6.2 Global 5 and 10 Largest Long Acting Drug Delivery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Long Acting Drug Delivery Industry Chain Analysis
4.1 Long Acting Drug Delivery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Long Acting Drug Delivery Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Long Acting Drug Delivery Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long Acting Drug Delivery Sales Market Share by Type (2019-2025)
6.3 Global Long Acting Drug Delivery Market Size Market Share by Type (2019-2025)
6.4 Global Long Acting Drug Delivery Price by Type (2019-2025)
7 Long Acting Drug Delivery Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long Acting Drug Delivery Market Sales by Application (2019-2025)
7.3 Global Long Acting Drug Delivery Market Size (M USD) by Application (2019-2025)
7.4 Global Long Acting Drug Delivery Sales Growth Rate by Application (2019-2025)
8 Long Acting Drug Delivery Market Consumption by Region
8.1 Global Long Acting Drug Delivery Sales by Region
8.1.1 Global Long Acting Drug Delivery Sales by Region
8.1.2 Global Long Acting Drug Delivery Sales Market Share by Region
8.2 North America
8.2.1 North America Long Acting Drug Delivery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Long Acting Drug Delivery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Long Acting Drug Delivery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Long Acting Drug Delivery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Long Acting Drug Delivery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Long Acting Drug Delivery Market Production by Region
9.1 Global Production of Long Acting Drug Delivery by Region (2019-2025)
9.2 Global Long Acting Drug Delivery Revenue Market Share by Region (2019-2025)
9.3 Global Long Acting Drug Delivery Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Long Acting Drug Delivery Production
9.4.1 North America Long Acting Drug Delivery Production Growth Rate (2019-2025)
9.4.2 North America Long Acting Drug Delivery Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Long Acting Drug Delivery Production
9.5.1 Europe Long Acting Drug Delivery Production Growth Rate (2019-2025)
9.5.2 Europe Long Acting Drug Delivery Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Long Acting Drug Delivery Production (2019-2025)
9.6.1 Japan Long Acting Drug Delivery Production Growth Rate (2019-2025)
9.6.2 Japan Long Acting Drug Delivery Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Long Acting Drug Delivery Production (2019-2025)
9.7.1 China Long Acting Drug Delivery Production Growth Rate (2019-2025)
9.7.2 China Long Acting Drug Delivery Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 ViiV Healthcare
10.1.1 ViiV Healthcare Long Acting Drug Delivery Basic Information
10.1.2 ViiV Healthcare Long Acting Drug Delivery Product Overview
10.1.3 ViiV Healthcare Long Acting Drug Delivery Product Market Performance
10.1.4 ViiV Healthcare Business Overview
10.1.5 ViiV Healthcare Long Acting Drug Delivery SWOT Analysis
10.1.6 ViiV Healthcare Recent Developments
10.2 Halozyme Therapeutics
10.2.1 Halozyme Therapeutics Long Acting Drug Delivery Basic Information
10.2.2 Halozyme Therapeutics Long Acting Drug Delivery Product Overview
10.2.3 Halozyme Therapeutics Long Acting Drug Delivery Product Market Performance
10.2.4 Halozyme Therapeutics Business Overview
10.2.5 Halozyme Therapeutics Long Acting Drug Delivery SWOT Analysis
10.2.6 Halozyme Therapeutics Recent Developments
10.3 Lubrizol Life Science
10.3.1 Lubrizol Life Science Long Acting Drug Delivery Basic Information
10.3.2 Lubrizol Life Science Long Acting Drug Delivery Product Overview
10.3.3 Lubrizol Life Science Long Acting Drug Delivery Product Market Performance
10.3.4 Lubrizol Life Science Long Acting Drug Delivery SWOT Analysis
10.3.5 Lubrizol Life Science Business Overview
10.3.6 Lubrizol Life Science Recent Developments
10.4 Celanese Corporation
10.4.1 Celanese Corporation Long Acting Drug Delivery Basic Information
10.4.2 Celanese Corporation Long Acting Drug Delivery Product Overview
10.4.3 Celanese Corporation Long Acting Drug Delivery Product Market Performance
10.4.4 Celanese Corporation Business Overview
10.4.5 Celanese Corporation Recent Developments
10.5 Kashiv BioSciences
10.5.1 Kashiv BioSciences Long Acting Drug Delivery Basic Information
10.5.2 Kashiv BioSciences Long Acting Drug Delivery Product Overview
10.5.3 Kashiv BioSciences Long Acting Drug Delivery Product Market Performance
10.5.4 Kashiv BioSciences Business Overview
10.5.5 Kashiv BioSciences Recent Developments
10.6 4P Therapeutics
10.6.1 4P Therapeutics Long Acting Drug Delivery Basic Information
10.6.2 4P Therapeutics Long Acting Drug Delivery Product Overview
10.6.3 4P Therapeutics Long Acting Drug Delivery Product Market Performance
10.6.4 4P Therapeutics Business Overview
10.6.5 4P Therapeutics Recent Developments
10.7 Ipsen
10.7.1 Ipsen Long Acting Drug Delivery Basic Information
10.7.2 Ipsen Long Acting Drug Delivery Product Overview
10.7.3 Ipsen Long Acting Drug Delivery Product Market Performance
10.7.4 Ipsen Business Overview
10.7.5 Ipsen Recent Developments
10.8 Midatech Pharma
10.8.1 Midatech Pharma Long Acting Drug Delivery Basic Information
10.8.2 Midatech Pharma Long Acting Drug Delivery Product Overview
10.8.3 Midatech Pharma Long Acting Drug Delivery Product Market Performance
10.8.4 Midatech Pharma Business Overview
10.8.5 Midatech Pharma Recent Developments
10.9 Re-Vana Therapeutics
10.9.1 Re-Vana Therapeutics Long Acting Drug Delivery Basic Information
10.9.2 Re-Vana Therapeutics Long Acting Drug Delivery Product Overview
10.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Product Market Performance
10.9.4 Re-Vana Therapeutics Business Overview
10.9.5 Re-Vana Therapeutics Recent Developments
10.10 Creative Biolabs
10.10.1 Creative Biolabs Long Acting Drug Delivery Basic Information
10.10.2 Creative Biolabs Long Acting Drug Delivery Product Overview
10.10.3 Creative Biolabs Long Acting Drug Delivery Product Market Performance
10.10.4 Creative Biolabs Business Overview
10.10.5 Creative Biolabs Recent Developments
11 Long Acting Drug Delivery Market Forecast by Region
11.1 Global Long Acting Drug Delivery Market Size Forecast
11.2 Global Long Acting Drug Delivery Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Long Acting Drug Delivery Market Size Forecast by Country
11.2.3 Asia Pacific Long Acting Drug Delivery Market Size Forecast by Region
11.2.4 South America Long Acting Drug Delivery Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Long Acting Drug Delivery by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Long Acting Drug Delivery Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Long Acting Drug Delivery by Type (2025-2032)
12.1.2 Global Long Acting Drug Delivery Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Long Acting Drug Delivery by Type (2025-2032)
12.2 Global Long Acting Drug Delivery Market Forecast by Application (2025-2032)
12.2.1 Global Long Acting Drug Delivery Sales (K Units) Forecast by Application
12.2.2 Global Long Acting Drug Delivery Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Long Acting Drug Delivery Market Size Comparison by Region (M USD)
Table 5. Global Long Acting Drug Delivery Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Long Acting Drug Delivery Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Long Acting Drug Delivery Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Long Acting Drug Delivery Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Drug Delivery as of 2022)
Table 10. Global Market Long Acting Drug Delivery Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Long Acting Drug Delivery Sales Sites and Area Served
Table 12. Manufacturers Long Acting Drug Delivery Product Type
Table 13. Global Long Acting Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Long Acting Drug Delivery
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Long Acting Drug Delivery Market Challenges
Table 22. Global Long Acting Drug Delivery Sales by Type (K Units)
Table 23. Global Long Acting Drug Delivery Market Size by Type (M USD)
Table 24. Global Long Acting Drug Delivery Sales (K Units) by Type (2019-2025)
Table 25. Global Long Acting Drug Delivery Sales Market Share by Type (2019-2025)
Table 26. Global Long Acting Drug Delivery Market Size (M USD) by Type (2019-2025)
Table 27. Global Long Acting Drug Delivery Market Size Share by Type (2019-2025)
Table 28. Global Long Acting Drug Delivery Price (USD/Unit) by Type (2019-2025)
Table 29. Global Long Acting Drug Delivery Sales (K Units) by Application
Table 30. Global Long Acting Drug Delivery Market Size by Application
Table 31. Global Long Acting Drug Delivery Sales by Application (2019-2025) & (K Units)
Table 32. Global Long Acting Drug Delivery Sales Market Share by Application (2019-2025)
Table 33. Global Long Acting Drug Delivery Sales by Application (2019-2025) & (M USD)
Table 34. Global Long Acting Drug Delivery Market Share by Application (2019-2025)
Table 35. Global Long Acting Drug Delivery Sales Growth Rate by Application (2019-2025)
Table 36. Global Long Acting Drug Delivery Sales by Region (2019-2025) & (K Units)
Table 37. Global Long Acting Drug Delivery Sales Market Share by Region (2019-2025)
Table 38. North America Long Acting Drug Delivery Sales by Country (2019-2025) & (K Units)
Table 39. Europe Long Acting Drug Delivery Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Long Acting Drug Delivery Sales by Region (2019-2025) & (K Units)
Table 41. South America Long Acting Drug Delivery Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Long Acting Drug Delivery Sales by Region (2019-2025) & (K Units)
Table 43. Global Long Acting Drug Delivery Production (K Units) by Region (2019-2025)
Table 44. Global Long Acting Drug Delivery Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Long Acting Drug Delivery Revenue Market Share by Region (2019-2025)
Table 46. Global Long Acting Drug Delivery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Long Acting Drug Delivery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Long Acting Drug Delivery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Long Acting Drug Delivery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Long Acting Drug Delivery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. ViiV Healthcare Long Acting Drug Delivery Basic Information
Table 52. ViiV Healthcare Long Acting Drug Delivery Product Overview
Table 53. ViiV Healthcare Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. ViiV Healthcare Business Overview
Table 55. ViiV Healthcare Long Acting Drug Delivery SWOT Analysis
Table 56. ViiV Healthcare Recent Developments
Table 57. Halozyme Therapeutics Long Acting Drug Delivery Basic Information
Table 58. Halozyme Therapeutics Long Acting Drug Delivery Product Overview
Table 59. Halozyme Therapeutics Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Halozyme Therapeutics Business Overview
Table 61. Halozyme Therapeutics Long Acting Drug Delivery SWOT Analysis
Table 62. Halozyme Therapeutics Recent Developments
Table 63. Lubrizol Life Science Long Acting Drug Delivery Basic Information
Table 64. Lubrizol Life Science Long Acting Drug Delivery Product Overview
Table 65. Lubrizol Life Science Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Lubrizol Life Science Long Acting Drug Delivery SWOT Analysis
Table 67. Lubrizol Life Science Business Overview
Table 68. Lubrizol Life Science Recent Developments
Table 69. Celanese Corporation Long Acting Drug Delivery Basic Information
Table 70. Celanese Corporation Long Acting Drug Delivery Product Overview
Table 71. Celanese Corporation Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Celanese Corporation Business Overview
Table 73. Celanese Corporation Recent Developments
Table 74. Kashiv BioSciences Long Acting Drug Delivery Basic Information
Table 75. Kashiv BioSciences Long Acting Drug Delivery Product Overview
Table 76. Kashiv BioSciences Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Kashiv BioSciences Business Overview
Table 78. Kashiv BioSciences Recent Developments
Table 79. 4P Therapeutics Long Acting Drug Delivery Basic Information
Table 80. 4P Therapeutics Long Acting Drug Delivery Product Overview
Table 81. 4P Therapeutics Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. 4P Therapeutics Business Overview
Table 83. 4P Therapeutics Recent Developments
Table 84. Ipsen Long Acting Drug Delivery Basic Information
Table 85. Ipsen Long Acting Drug Delivery Product Overview
Table 86. Ipsen Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Ipsen Business Overview
Table 88. Ipsen Recent Developments
Table 89. Midatech Pharma Long Acting Drug Delivery Basic Information
Table 90. Midatech Pharma Long Acting Drug Delivery Product Overview
Table 91. Midatech Pharma Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Midatech Pharma Business Overview
Table 93. Midatech Pharma Recent Developments
Table 94. Re-Vana Therapeutics Long Acting Drug Delivery Basic Information
Table 95. Re-Vana Therapeutics Long Acting Drug Delivery Product Overview
Table 96. Re-Vana Therapeutics Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Re-Vana Therapeutics Business Overview
Table 98. Re-Vana Therapeutics Recent Developments
Table 99. Creative Biolabs Long Acting Drug Delivery Basic Information
Table 100. Creative Biolabs Long Acting Drug Delivery Product Overview
Table 101. Creative Biolabs Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Creative Biolabs Business Overview
Table 103. Creative Biolabs Recent Developments
Table 104. Global Long Acting Drug Delivery Sales Forecast by Region (2025-2032) & (K Units)
Table 105. Global Long Acting Drug Delivery Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Long Acting Drug Delivery Sales Forecast by Country (2025-2032) & (K Units)
Table 107. North America Long Acting Drug Delivery Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Long Acting Drug Delivery Sales Forecast by Country (2025-2032) & (K Units)
Table 109. Europe Long Acting Drug Delivery Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Long Acting Drug Delivery Sales Forecast by Region (2025-2032) & (K Units)
Table 111. Asia Pacific Long Acting Drug Delivery Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Long Acting Drug Delivery Sales Forecast by Country (2025-2032) & (K Units)
Table 113. South America Long Acting Drug Delivery Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Long Acting Drug Delivery Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Long Acting Drug Delivery Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Long Acting Drug Delivery Sales Forecast by Type (2025-2032) & (K Units)
Table 117. Global Long Acting Drug Delivery Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Long Acting Drug Delivery Price Forecast by Type (2025-2032) & (USD/Unit)
Table 119. Global Long Acting Drug Delivery Sales (K Units) Forecast by Application (2025-2032)
Table 120. Global Long Acting Drug Delivery Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Long Acting Drug Delivery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long Acting Drug Delivery Market Size (M USD), 2019-2032
Figure 5. Global Long Acting Drug Delivery Market Size (M USD) (2019-2032)
Figure 6. Global Long Acting Drug Delivery Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long Acting Drug Delivery Market Size by Country (M USD)
Figure 11. Long Acting Drug Delivery Sales Share by Manufacturers in 2023
Figure 12. Global Long Acting Drug Delivery Revenue Share by Manufacturers in 2023
Figure 13. Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Long Acting Drug Delivery Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Long Acting Drug Delivery Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Long Acting Drug Delivery Market Share by Type
Figure 18. Sales Market Share of Long Acting Drug Delivery by Type (2019-2025)
Figure 19. Sales Market Share of Long Acting Drug Delivery by Type in 2023
Figure 20. Market Size Share of Long Acting Drug Delivery by Type (2019-2025)
Figure 21. Market Size Market Share of Long Acting Drug Delivery by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Long Acting Drug Delivery Market Share by Application
Figure 24. Global Long Acting Drug Delivery Sales Market Share by Application (2019-2025)
Figure 25. Global Long Acting Drug Delivery Sales Market Share by Application in 2023
Figure 26. Global Long Acting Drug Delivery Market Share by Application (2019-2025)
Figure 27. Global Long Acting Drug Delivery Market Share by Application in 2023
Figure 28. Global Long Acting Drug Delivery Sales Growth Rate by Application (2019-2025)
Figure 29. Global Long Acting Drug Delivery Sales Market Share by Region (2019-2025)
Figure 30. North America Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Long Acting Drug Delivery Sales Market Share by Country in 2023
Figure 32. U.S. Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Long Acting Drug Delivery Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Long Acting Drug Delivery Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Long Acting Drug Delivery Sales Market Share by Country in 2023
Figure 37. Germany Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Long Acting Drug Delivery Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Long Acting Drug Delivery Sales Market Share by Region in 2023
Figure 44. China Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Long Acting Drug Delivery Sales and Growth Rate (K Units)
Figure 50. South America Long Acting Drug Delivery Sales Market Share by Country in 2023
Figure 51. Brazil Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Long Acting Drug Delivery Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Long Acting Drug Delivery Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Long Acting Drug Delivery Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Long Acting Drug Delivery Production Market Share by Region (2019-2025)
Figure 62. North America Long Acting Drug Delivery Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Long Acting Drug Delivery Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Long Acting Drug Delivery Production (K Units) Growth Rate (2019-2025)
Figure 65. China Long Acting Drug Delivery Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Long Acting Drug Delivery Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Long Acting Drug Delivery Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Long Acting Drug Delivery Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Long Acting Drug Delivery Market Share Forecast by Type (2025-2032)
Figure 70. Global Long Acting Drug Delivery Sales Forecast by Application (2025-2032)
Figure 71. Global Long Acting Drug Delivery Market Share Forecast by Application (2025-2032)
